SAFETY OF LOW-DOSE PROLONGED INFUSION OF TISSUE PLASMINOGEN ACTIVATOR THERAPY IN PATIENTS WITH THROMBOEMBOLIC EVENTS IN THE INTENSIVE CARE UNIT


Kalkan M. E. , Yildiz M., YILMAZ AK H. , Agus H. Z. , ÖZŞAHİN Y. , AYKAN A. Ç. , ...Daha Fazla

KARDIOLOGIYA, cilt.60, sa.7, ss.86-90, 2020 (SCI İndekslerine Giren Dergi) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 60 Konu: 7
  • Basım Tarihi: 2020
  • Doi Numarası: 10.18087/cardio.2020.7.n1091
  • Dergi Adı: KARDIOLOGIYA
  • Sayfa Sayıları: ss.86-90

Özet

Objective Thromboembolic events such as acute coronary syndrome related prosthetic heart valve thrombosis, pulmonary artery embolism and renal artery embolism are a rare condition but a major cause of morbidity and mortality. In this study we discussed low-dose thrombolytic therapy, in patients with thromboembolic events in the intensive care unit.